Related Experiment Video
Updated: Jul 5, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.9K
[Update on point-of-care-based coagulation treatment : Systems, reagents, device-specific treatment algorithms]
Felix C F Schmitt1, Herbert Schöchl2,3, Kathrin Brün4
1Klinik für Anästhesiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Deutschland. felix.schmitt@med.uni-heidelberg.de.
Die Anaesthesiologie
|January 23, 2024
Summary
Viscoelastic testing (VET) devices are widely used for point-of-care (POC) diagnostics. This article updates VET treatment algorithms, presenting an overview of current devices and reagents for improved clinical application.
Area of Science:
- Biomedical Engineering
- Clinical Diagnostics
- Medical Devices
Context:
- Viscoelastic testing (VET) is a crucial point-of-care (POC) diagnostic method widely adopted in clinical settings.
- The field has seen significant advancements in devices, test methodologies, and reagents.
- Existing treatment algorithms require updating to reflect these technological and methodological evolutions.
Purpose:
- To provide a comprehensive overview of currently available VET devices and their associated reagents.
- To present updated treatment algorithms tailored for the most prevalent VET devices used in German-speaking regions.
- To guide clinicians in optimizing the use of VET for patient care.
Summary:
- This article reviews the landscape of viscoelastic testing (VET) devices and reagents suitable for point-of-care (POC) use.
- It highlights the necessity of updating current treatment algorithms due to recent advancements in VET technology and methods.
- Two specific treatment algorithms for commonly used VET devices in German-speaking countries are detailed.
Impact:
- Facilitates informed selection and utilization of VET devices in clinical practice.
- Enhances the accuracy and efficiency of POC diagnostics through updated treatment protocols.
- Supports healthcare professionals in German-speaking countries with evidence-based VET management strategies.
Related Concept Videos
Coagulation
6.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Introduction to Hemostasis
7.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.8K

